There was also an increase in IGFBP-2 levels, while there is no direct evidence of the relationship between IGFBP-2 and CLL, it is highly expressed in certain human acute leukemia cells, and it supports the activity of hematopoietic stem cells (HSCs) [51]. This evidence concerns the gene IGFBP2 and B-cell chronic lymphocytic leukemia.